Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
conference save search
VistaGen to Participate at William Blair Biotech Focus Conference 2022
Published: 2022-07-07 (Crawled : 13:00) - biospace.com/
VTGN | $4.77 1.49% 1.47% 150K
|
Health Technology
|
| O: 3005.68%
H: 6.47%
C: 5.18%
conference biotech
Canoo to Participate at Upcoming Investor Conferences
Published: 2024-03-07 (Crawled : 11:00) - globenewswire.com
GOEV A | $2.83 -5.67% -6.01% 3.6M
|
|
| O: 2200.0%
H: 25.58%
C: 14.06%
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in September
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 737.5%
H: 0.0%
C: 0.0%
therapeutics
U. S. Well Services Announces Second Quarter 2022 Earnings Release Date and Conference Call
Published: 2022-08-05 (Crawled : 11:00) - prnewswire.com
USWS | $7.41 2.63% 1.21%
|
Finance
|
| O: 471.43%
H: 0.0%
C: 0.0%
conference services
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
Published: 2023-03-13 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 241.08%
H: 0.62%
C: 0.08%
conference year
Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503, Novel Immuno-Oncology Pre-Clinical Program Harnessing IL-18 Biology
Published: 2023-12-19 (Crawled : 12:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 178.08%
H: 21.18%
C: -1.48%
com503 conference pre-clinical license il-18 program agreement
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
Published: 2024-03-01 (Crawled : 13:00) - globenewswire.com
BIVI | $0.4874 -0.21% -0.21% 490K
|
Health Technology
|
| O: 141.13%
H: 10.7%
C: -36.79%
ne3107 conference disease alzheimer’s international parkinson’s potential
Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
Published: 2023-10-12 (Crawled : 14:00) - biospace.com/
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 102.48%
H: 7.96%
C: -27.76%
conference health
Acumen Pharmaceuticals to Hold Conference Call to Discuss Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease
Published: 2023-07-17 (Crawled : 11:00) - globenewswire.com
ABOS | $3.14 -0.63% -0.64% 310K
|
Professional, Scientific, and T...
|
| O: 75.32%
H: 2.72%
C: -11.72%
acu193 conference disease alzheimer’s positive pharmaceuticals topline results study
Sotera Health Chairman and CEO Presents at 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-09 (Crawled : 23:00) - globenewswire.com
SHC | $10.95 0.46% 0.46% 950K
|
Commercial Services
|
| O: 74.77%
H: 17.81%
C: 14.24%
ceo conference health
Vaxcyte to Host Webcast and Conference Call to Discuss Topline Results from the Phase 1/2 Proof-of-Concept Study of VAX-24 Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults
Published: 2022-10-23 (Crawled : 00:00) - globenewswire.com
PCVX | $60.82 0.33% 0.33% 1.3M
|
Health Technology
|
| O: 70.8%
H: 2.7%
C: -6.12%
STRO | $3.635 -3.58% -3.71% 520K
|
Health Technology
|
| O: 0.71%
H: 14.96%
C: 13.91%
vax-24 conference disease topline study pneumococcal
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101
Published: 2021-10-03 (Crawled : 00:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 69.5%
H: 22.03%
C: 18.82%
phase 2 results topline phase 2b trial conference
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
Published: 2022-12-22 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.19%
H: 0.66%
C: -0.55%
PRQR | News | $1.965 5.65% 5.34% 130K
|
Health Technology
|
| O: 64.85%
H: 13.97%
C: -0.74%
axiomer conference platform
Immunovant to Host Conference Call and Webcast to Report Initial IMVT-1402 Phase 1 Results on September 26, 2023
Published: 2023-09-26 (Crawled : 03:00) - globenewswire.com
IMVT S | $28.24 -0.28% -0.28% 1.1M
|
Health Technology
|
| O: 59.22%
H: 29.2%
C: 23.75%
imvt-1402 conference report results
Humanigen to Host Conference Call to Report Phase 3 Topline Results of LenzilumabTM in Patients Hospitalized With COVID-19
Published: 2021-03-29 (Crawled : 14:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 57.11%
H: 32.85%
C: -1.68%
covid results topline lenzilumab phase 3 conference
Castle Biosciences to Present New DecisionDx®-SCC and DecisionDx®-Melanoma Data at the American Head & Neck Society’s (AHNS) 11th International Conference on Head and Neck Cancer
Published: 2023-07-07 (Crawled : 15:00) - biospace.com/
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
|
| O: 50.6%
H: 4.8%
C: 1.5%
decisiondx conference cancer international
Merus Presents Early Clinical Data on MCLA-158 and Preclinical Data on Zenocutuzumab at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 45.75%
H: 2.13%
C: -5.69%
molecular cancer conference preclinical pre-clinical
Taysha Gene Therapies to Host Conference Call to Discuss Astellas Pharma’s Strategic Investment to Support the Development of Taysha’s AAV-based Gene Therapy Programs
Published: 2022-10-24 (Crawled : 00:00) - globenewswire.com
TSHA | $2.265 -6.02% -6.4% 1.8M
|
Health Technology
|
| O: 45.7%
H: 36.36%
C: 35.45%
conference therapy
Apogee to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases on March 5, 2024
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
APGE | $46.98 -2.83% -2.92% 470K
|
|
| O: 43.53%
H: 9.18%
C: -1.02%
apg777 conference report antibody dermatitis treatment trial results
Finch Therapeutics to Present at Upcoming Virtual Investor Conferences - May 28, 2021
Published: 2021-05-28 (Crawled : 12:00) - biospace.com/
FNCH | $2.205 -6.57% -7.03% 30K
|
Professional, Scientific, and T...
|
| O: 43.51%
H: 0.0%
C: -33.98%
conference
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.